β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.
about
MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerFunctional Role of the microRNA-200 Family in Breast Morphogenesis and NeoplasiaExtracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancerCellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour.The role of integrins in TGFβ activation in the tumour stromaExtracellular matrix as target for antitumor therapymicroRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.Flipping the switch: integrin switching provides metastatic competenceCDK7-dependent transcriptional addiction in triple-negative breast cancer.Structural ECM components in the premetastatic and metastatic niche.In PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I.A cell-ECM screening method to predict breast cancer metastasis.Tumor-induced remote ECM network orientation steers angiogenesis.NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.ITIH5 mediates epigenetic reprogramming of breast cancer cells.Deletion of β-1 integrin in collecting duct principal cells leads to tubular injury and renal medullary fibrosis.Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.Actin cytoskeleton regulates functional anchorage-migration switch during T-cadherin-induced phenotype modulation of vascular smooth muscle cells.Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.Tuning Collective Cell Migration by Cell-Cell Junction Regulation.The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer.A new method to study the change of miRNA-mRNA interactions due to environmental exposures.The renaissance of anti-neoplastic immunity from tumor cell demise.MicroRNAs and cancer: Key paradigms in molecular therapy.β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.Applications of RNA Indexes for Precision Oncology in Breast Cancer
P2860
Q26777313-40CA0C36-021E-4D9C-A715-E641FD5D933CQ26861636-9F7F6225-6310-4FBE-A058-C24766856EA0Q27005909-3993C2CB-06AB-43CC-B64B-51B8C9CE25B3Q27316544-BDC5DBEE-CA58-4D78-8122-78011092A044Q28068373-72D6303A-AB70-4A6C-89A3-955D9FA1EB0CQ28082018-B7DDCA91-AE89-40AE-B5AC-F43E691CE699Q33779244-180659E9-DBAD-4939-80DA-6F81EDD9F467Q34402680-4324B125-1EB9-49B2-80A4-21D70409285AQ34495729-2978EA59-595F-42F1-9CC4-A3262772A628Q34521147-0FB921E4-278B-4F30-92D0-C3313995CE11Q35040814-FB8DFE7D-BEDA-4DB3-AB01-A0D1290C6B62Q35070945-C7596DAA-A7DE-4569-BDFE-BA9248EAFEC1Q35941690-CB0C25CE-E0C8-4D7B-8C87-CC408A1D84DBQ36811554-2237C1D3-8E83-490C-AD01-CB80577EC07FQ37400824-C2EF6438-4C00-453C-B073-D94DF99035F3Q37661492-9790DD2C-7339-4739-B72E-0E0659891A64Q38682109-73564EB9-2905-4C37-9746-26EBAFA58256Q38733122-7759259C-9FA7-4463-8A50-69075199C672Q38772722-B1A45E85-6DB6-4858-AF8F-9FEA7211F43DQ38775027-9C302583-5EC9-4E9A-8A0A-F65DDC6661CDQ38814412-B99DBE8B-F85A-4283-B764-69B8C7E65850Q39092645-B7250148-83FC-40E6-84DC-8FF5D223B3B6Q47213893-70C2E61F-DCDE-4037-A51E-6692E430220FQ47322221-FBE6FC7D-A118-44F9-8B73-59F7ECB5FCEEQ48193643-DB884B87-D381-4797-A6AA-87A5C8F6C905Q49424922-F62DB159-7268-4CF3-8110-A84DE19F57A2Q52647715-CE1F6F61-65C6-4C1D-B75A-1E7B1DADD53DQ53500903-921974FE-BD7B-4F5A-8F9B-CE4140770077Q54231260-54D3AAC1-B32D-40A7-9C3B-D941AA66E5BEQ57113927-D601B534-76E3-4898-88E3-1000C637A56B
P2860
β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@en
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@nl
type
label
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@en
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@nl
prefLabel
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@en
β1 integrin inhibition elicits ...... triple-negative breast cancer.
@nl
P2093
P2860
P50
P1433
P1476
β1 integrin inhibition elicits ...... triple-negative breast cancer
@en
P2093
B Ewa Snaar-Jagalska
Bob van de Water
Ella Nirmala
Erno Vreugdenhil
Hoa H Truong
Jiangling Xiong
John H N Meerman
Lizette Haazen
Shuning He
Veerander P S Ghotra
P2860
P356
10.1126/SCISIGNAL.2004751
P577
2014-02-11T00:00:00Z